Revamilast
- Generic Name
- Revamilast
- Drug Type
- Small Molecule
- Chemical Formula
- C18H9Cl2F2N3O4
- CAS Number
- 893555-90-3
- Unique Ingredient Identifier
- 30LE65637T
- Background
Revamilast has been used in trials studying the treatment of Asthma and Rheumatoid Arthritis.
A Clinical Trial to Study the Effects of Revamilast in Patients With Chronic Persistent Asthma
- First Posted Date
- 2011-09-20
- Last Posted Date
- 2013-06-21
- Lead Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Target Recruit Count
- 273
- Registration Number
- NCT01436890
- Locations
- 🇮🇳
Dr Khippal's Clinic, Jaipur, Rajasthan, India
🇮🇳Chest and Maternity Centre, Bangalore, Karnataka, India
🇮🇳Narayana Medical College & Hospital, Nellore, Andhra Pradesh, India
A Clinical Trial to Study the Effects of Revamilast in Patients With Rheumatoid Arthritis
- First Posted Date
- 2011-09-08
- Last Posted Date
- 2012-12-28
- Lead Sponsor
- Glenmark Pharmaceuticals Ltd. India
- Target Recruit Count
- 406
- Registration Number
- NCT01430507
- Locations
- 🇮🇳
M S Ramaiah Medical College and Hospital, Bangalore, Karnataka, India
🇵🇱Oddział Kliniczny Reumatologii i Ukladowych Chorob Tkanki Lacznej, Bydgoszcz, Wojewodztwo kujawsko pomorskie, Poland
🇵🇱NZOZ Reumed, Lublin, Wojewodztwo lubelskie, Poland
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath